Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 9 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Preclinical Testing of Tunable Cytokine Receptors
Moriarity, B. S. & Felices, M.
8/14/19 → 8/13/21
Project: Research project
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
Genetically Modified Natural Killer Cells for Cancer Immunotherapy
Moriarity, B. S. & Felices, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/6/18 → 8/31/20
Project: Research project
Next Generation TriKE Development: EpCAM, otherTriKEs
Miller, J. S., Felices, M. & Vallera, D. A.
10/1/16 → 7/1/19
Project: Research project
Research Output
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C. L., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K. & Moriarity, B. S., Jan 8 2020, In : Molecular Therapy. 28, 1Research output: Contribution to journal › Article
Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
Uppendahl, L. D., Felices, M., Bendzick, L., Ryan, C., Kodal, B., Hinderlie, P., Boylan, K. L. M., Skubitz, A. P. N., Miller, J. S. & Geller, M. A., Apr 2019, In : Gynecologic oncology. 153, 1, p. 149-157 9 p.Research output: Contribution to journal › Article
4
Scopus
citations
Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
Yun, H. D., Schirm, D. K., Felices, M., Miller, J. S. & Eckfeldt, C. E., Aug 27 2019, In : Blood Advances. 3, 16, p. 2448-2452 5 p.Research output: Contribution to journal › Article
Open Access
1
Scopus
citations
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL
Felices, M., Kodal, B., Hinderlie, P., Kaminski, M. F., Cooley, S., Weisdorf, D. J., Vallera, D. A., Miller, J. S. & Bachanova, V., Mar 26 2019, In : Blood Advances. 3, 6, p. 897-907 11 p.Research output: Contribution to journal › Article
Open Access
5
Scopus
citations
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
Sarhan, D., Brandt, L., Felices, M., Guldevall, K., Lenvik, T., Hinderlie, P., Curtsinger, J., Warlick, E., Spellman, S. R., Blazar, B. R., Weisdorf, D. J., Cooley, S., Vallera, D. A., Onfelt, B. & Miller, J. S., Jun 26 2018, In : Blood Advances. 2, 12, p. 1459-1469 11 p.Research output: Contribution to journal › Article
Open Access
12
Scopus
citations